⚠ You're viewing a report from July 2022. Subscribe to get the latest →

FDA Enforcement — July 2022 Report

Automated analysis of 39 items from public government data sources. Updated daily.

Summary

39
Total items
20
High impact
19
Medium impact
0
Low impact

High-impact items this period

Chaur Fong Inc. dba 888 Food Company
Seafood prepared under insanitary conditions, HACCP violations
Why: Non-compliance with seafood HACCP and CGMP food safety standards  ·  Jul 29  ·  Impact: HIGH
The Royal Ice Cream Company Inc.
Food prepared under insanitary conditions with L. monocytogenes
Why: CGMP and food safety violations, pathogenic contamination detected  ·  Jul 28  ·  Impact: HIGH
Vitti Labs, LLC
HCT/P regulatory deviations in human cells and tissues handling
Why: Non-compliance with CFR regulations for human cellular products  ·  Jul 28  ·  Impact: HIGH
Sagent Pharmaceuticals, Inc.
CGMP violations in drug manufacturing operations
Why: Adulterated drugs from inadequate manufacturing and quality controls  ·  Jul 27  ·  Impact: HIGH
Jose Miguel Gutierrez Salas
Unapproved drug distribution and registration violations
Why: Marketing unapproved pharmaceuticals without proper registration and listing  ·  Jul 21  ·  Impact: HIGH
Guangzhou Orchard Aromatherapy & Skin Care Co., Ltd.
Refusal to provide FDA access to records and documentation
Why: Non-compliance with FDA inspection authority and record access requirements  ·  Jul 20  ·  Impact: HIGH
DSP Skin Care LLC
Pharmaceutical CGMP violations with adulterated product
Why: Current Good Manufacturing Practice non-compliance in finished pharmaceuticals  ·  Jul 19  ·  Impact: HIGH
Jost Chemical Co.
API active pharmaceutical ingredient CGMP adulteration violations
Why: Failure to maintain current good manufacturing practices for APIs  ·  Jul 18  ·  Impact: HIGH
Daniel Fred Goodman, M.D./Goodman Eye Center
IRB and bioresearch monitoring program violations
Why: Institutional Review Board oversight and compliance failures  ·  Jul 14  ·  Impact: HIGH
Zyno Medical LLC
Manufacturing adulterated medical devices
Why: CGMP/QSR violations resulted in adulterated medical device production  ·  Jul 12  ·  Impact: HIGH

Selected medium-impact items

Deggeh Foods, Inc.
Marketed unapproved new drugs; product misbranded
Why: Drug products marketed without approval and with improper labeling  ·  Jul 29  ·  Impact: MEDIUM
EH Maldonado and Company
Foreign supplier verification program deficiencies
Why: Inadequate verification of imported food supplier safety controls  ·  Jul 28  ·  Impact: MEDIUM
Tiger Vapor, LLC
Tobacco Control Act violations: adulterated misbranded vaping
Why: Distributing unapproved adulterated tobacco vaping products  ·  Jul 25  ·  Impact: MEDIUM
Bacocas Enterprises Inc.
Foreign supplier verification program deficiencies
Why: Inadequate supplier verification procedures for imported food products  ·  Jul 25  ·  Impact: MEDIUM
Muscle Feast, LLC
Adulterated dietary supplement CGMP manufacturing violations
Why: Non-compliance with manufacturing and labeling standards  ·  Jul 22  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →